BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32554982)

  • 1. Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation: A Meta-analysis.
    Viani GA; Arruda CV; De Fendi LI
    Am J Clin Oncol; 2020 Aug; 43(8):575-581. PubMed ID: 32554982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
    Sumodhee S; Bondiau PY; Poudenx M; Cohen C; Naghavi AO; Padovani B; Maneval D; Gal J; Leysalle A; Ghalloussi H; Otto J; Doyen J
    BMC Cancer; 2019 Apr; 19(1):305. PubMed ID: 30943943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis.
    Lee TH; Kim DY; Wu HG; Lee JH; Kim HJ
    Radiat Oncol; 2021 Nov; 16(1):222. PubMed ID: 34794471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis.
    Safavi AH; Mak DY; Boldt RG; Chen H; Louie AV
    Lung Cancer; 2021 Oct; 160():179-186. PubMed ID: 34330566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.
    Chen H; Laba JM; Zayed S; Boldt RG; Palma DA; Louie AV
    J Thorac Oncol; 2019 Aug; 14(8):1332-1342. PubMed ID: 31075543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes.
    Shanker MD; Moodaley P; Soon W; Liu HY; Lee YY; Pryor DI
    J Med Imaging Radiat Oncol; 2021 Dec; 65(7):956-968. PubMed ID: 34396706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy to treat breast cancer oligometastases: A systematic review with meta-analysis.
    Viani GA; Gouveia AG; Louie AV; Korzeniowski M; Pavoni JF; Hamamura AC; Moraes FY
    Radiother Oncol; 2021 Nov; 164():245-250. PubMed ID: 34624408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
    Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
    Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer.
    Robinson M; O'Cathail S; Duffton A; Aitken K; Muirhead R
    Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):571-577. PubMed ID: 35504797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
    Sahin B; Atalar B; Kaytan Saglam E; Akgun Z; Abacioglu U; Arifoglu A; Ozyar E; Yaprak G; Ozseker Isik N; Guney Y; Caglar HB; Karaman S; Igdem S; Selek U; Berber T; Oner Dincbas F; Sengoz M; Yucel S; Demiral AN; Akyurek S
    Clin Respir J; 2020 Nov; 14(11):1050-1059. PubMed ID: 32749053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors.
    Atalar B; Mustafayev TZ; Sio TT; Sahin B; Gungor G; Aydın G; Yapici B; Ozyar E
    Radiol Oncol; 2020 Jun; 54(4):480-487. PubMed ID: 32589607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis.
    Hegi F; D'Souza M; Azzi M; De Ruysscher D
    Clin Lung Cancer; 2018 May; 19(3):199-212. PubMed ID: 29370978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma.
    McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG
    Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
    Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
    Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
    Murray LJ; Lilley J; Hawkins MA; Henry AM; Dickinson P; Sebag-Montefiore D
    Radiother Oncol; 2017 Nov; 125(2):213-222. PubMed ID: 29066125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non-small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes.
    Sood S; Ganju R; Shen X; Napel MT; Wang F
    Clin Lung Cancer; 2021 May; 22(3):e301-e312. PubMed ID: 33132058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
    Chen H; Laba JM; Boldt RG; Goodman CD; Palma DA; Senan S; Louie AV
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):186-194. PubMed ID: 29619964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.